CPC C07K 14/001 (2013.01) [A61P 31/14 (2018.01); C07K 2319/00 (2013.01)] | 6 Claims |
1. A method for conducting a human coronavirus 229E inhibition assay comprising:
(a) providing a HCoV-229E peptide inhibitor;
(b) providing a test inhibitor;
(c) assaying the HCoV-229E peptide inhibitor to obtain results for the HCoV-229E peptide inhibitor;
(d) assaying the test inhibitor to obtain results for the test inhibitor; and
(e) comparing the results for the HCoV-229 peptide inhibitor to the results for the test inhibitor to determine whether the test inhibitor inhibits HCoV-229 fusion;
wherein the HCoV-229E peptide inhibitor is selected from the group consisting of a peptide consisting of the amino acid sequence of SEQ ID NO: 2, a peptide consisting of the amino acid sequence of SEQ ID NO: 3, and a peptide consisting of the amino acid sequence of SEQ ID NO: 2 and the amino acid sequence of SEQ ID NO: 3, and a combination thereof.
|